>
网站首页期刊介绍通知公告编 委 会投稿须知电子期刊广告合作联系我们
最新消息:
盆腔炎性疾病患者血清miR-140-5p、TLR4的表达水平及其临床意义
作者:谢凤  曾敏  蔡梦瑶  陈妍 
单位:成都市中西医结合医院·成都市第一人民医院 妇产科, 四川 成都 610095
关键词:盆腔炎性疾病 miR-140-5p Toll样受体4 
分类号:R711.33
出版年·卷·期(页码):2023·42·第六期(909-914)
摘要:

目的:探讨盆腔炎性疾病(PID)患者血清中miR-140-5p、Toll样受体4(TLR4)的表达水平及其临床意义,旨在为诊断和治疗PID患者提供相关依据。方法:选取2020年10月至2021年10月本院收治的132例PID患者为PID组,100例体检健康人群作为对照组;采用实时荧光定量PCR(RT-qPCR)技术检测miR-140-5p、TLR4表达水平;采用酶联免疫吸附法(ELISA)检测TNF-α、IL-6、IL-4和IL-1β的含量;Pearson法分析miR-140-5p、TLR4的相关性以及二者与TNF-α、IL-6、IL-4、IL-1β的相关性;绘制ROC曲线分析miR-140-5p、TLR4对PID的诊断价值。结果:PID组血清miR-140-5p表达水平显著低于对照组,TLR4的表达水平显著高于对照组(P<0.05),二者表达水平具有负相关关系(P<0.05);随着PID严重程度增加miR-140-5p的表达水平降低,TLR4的表达水平升高(P<0.05);PID组患者血清TNF-α、IL-6、IL-1β水平较对照组显著升高,IL-4水平显著降低(P<0.05);miR-140-5p与TNF-α、IL-6、IL-1β水平均呈负相关,与IL-4水平呈正相关(P<0.05);TLR4与TNF-α、IL-6、IL-1β水平均呈正相关,与IL-4水平呈负相关(P<0.05);二者联合诊断的AUC高于miR-140-5p、TLR4单独诊断的AUC(Z=2.214,P<0.001;Z=2.012,P=0.031)。结论:PID患者血清中miR-140-5p表达水平显著降低,TLR4表达水平显著升高,二者联合对PID具有一定的诊断价值。

Objective: To investigate the expression level of miR-140-5p and Toll-like receptor 4(TLR4) in serum of patients with pelvic inflammatory disease(PID) and their clinical significance, in order to provide relevant basis for diagnosis and treatment of patients with PID. Methods: From October 2020 to October 2021, 132 PID patients admitted to our hospital were included in the PID group, and 100 healthy people with physical examination were included in the control group; real-time quantitative PCR(RT-qPCR) technology was applied to detect the expression levels of miR-140-5p and TLR4; enzyme-linked immunosorbent assay(ELISA) was applied to detect the levels of TNF-α, IL-6, IL-4 and IL-1β; Pearson method was applied to analyze the correlation between miR-140-5p and TLR4 and their correlation with TNF-α, IL-6, IL-4 and IL-1β; ROC curve was drawn to analyze the diagnostic value of miR-140-5p and TLR4 for PID. Results: The expression level of serum miR-140-5p in the PID group was greatly lower than that in the control group, and the expression level of TLR4 was greatly higher than that in the control group(P<0.05), and the two expression levels were negatively correlated(P<0.05); with the increase of PID severity, the expression level of miR-140-5p decreased, and the expression level of TLR4 increased(P<0.05); the serum levels of TNF-α, IL-6 and IL-1β in the PID group were greatly higher than those in the control group, and the level of IL-4 was greatly lower(P<0.05); miR-140-5p was negatively correlated with the levels of TNF-α, IL-6 and IL-1β, and positively correlated with the level of IL-4(P<0.05); TLR4 was positively correlated with the levels of TNF-α, IL-6, IL-1β, and negatively correlated with the level of IL-4(P<0.05); the AUC of the combined diagnosis was higher than that of miR-140-5p and TLR4 alone(Z=2.214,P<0.001;Z=2.012,P=0.031). Conclusion: The expression level of miR-140-5p in serum of PID patients was greatly decreased, and the expression level of TLR4 was greatly increased. The combination of the two has certain diagnostic value for PID.

参考文献:

[1] 霍志平,李红霞,王宏利,等.盆腔炎性疾病后遗症患者外周血miR-34a、SIRT1的表达及临床意义[J].临床和实验医学杂志,2022,21(5):525-529.
[2] LIU L,TANG W,LI C,et al.P314 risk of infertility in relation to chlamydia and pelvic inflammatory disease:a case-control study in Chinese population[J].Abstr STI HIV World Cong,2021,97(1):14-17.
[3] 徐佳月,朱晓东.抗生素降阶梯治疗在临床应用的再探讨[J].中国小儿急救医学,2022,29(4):255-259.
[4] 冯晓玲,蒋莎,陈璐,等.妇炎舒胶囊联合抗生素治疗慢性盆腔炎疗效分析[J].中华中医药学刊,2020,38(3):24-28.
[5] TAN H,REN R,ZHANG J,et al.Analysis of inflammation-related microRNA expression in patients with ankylosing spondylitis[J].Immunol Res,2021,70(1):23-32.
[6] NAGY B J R,NAGY B,FILA L,et al.Human epididymis protein 4:a novel serum inflammatory biomarker in cystic fibrosis[J].Chest,2016,150(3):661-672.
[7] GUOP Y,WU L F,XIAO Z Y,et al.Knockdown of MiR-140-5 promotes osteogenesis of adipose-derived mesenchymal stem cells by targeting TLR4 and BMP2 and promoting fracture healing in the atrophic nonunion rat model[J].Eur Rev Med Pharmacol Sci,2019,23(5):2112-2124.
[8] 刘志刚,李琦军,王飞,等.miR-140-5p通过NF-κB通路调控人骨关节炎软骨细胞自噬的研究[J].现代中西医结合杂志,2020,29(19):2089-2093.
[9] SONGIA P,CHIESA M,ALFIERI V,et al.Putative circulating MicroRNAs are able to identify patients with mitral valve prolapse and severe regurgitation[J].Int J Mol Sci,2021,22(4):2102-2115.
[10] TANG H,ZENG Q,REN N,et al.Kaempferide improves oxidative stress and inflammation by inhibiting the TLR4/IκBα/NF-κB pathway in obese mice[J].Iran J Basic Med Sci, 2021,24(4):493-498.
[11] 屠道远,甄林林,李振,等.Toll样受体2/4在非哺乳期乳腺炎组织中的表达及意义[J].中华乳腺病杂志(电子版),2020,14(2):92-97.
[12] 中华医学会妇产科学分会感染性疾病协作组.盆腔炎症性疾病诊治规范(2019修订版)[J].中华妇产科杂志,2019,54(7):433-437.
[13] WANG X,SHI W,SHI X,et al.The effect of adjuvant treatment in chronic pelvic inflammation by Fukejing capsules and its influence on hemorheology and inflammatory factors[J].Am J Translat Res,2021,13(4):3480-3486.
[14] CHEN J,ZHANG L G,DU H X,et al.Melatonin attenuates prostatic inflammation and pelvic pain via Sirt1-dependent inhibition of the NLRP3 inflammasome in an EAP mouse model[J].Prostate,2021,81(15):1179-1190.
[15] 何美秀,彭卫东.盆腔炎性疾病六经辨证分型规律探讨及临证应用[J].现代中西医结合杂志,2021,30(5):507-510.
[16] SOLEIMANI M,THI M,SAXENA N,et al.Plasma exosome microRNAs in patients with advanced renal cell carcinoma treated with nivolumab and ipilimumab:Potential biomarkers of response to therapy[J].J Clin Oncol,2021,39(6_suppl):338.
[17] 李元昆.外泌体中miR-483-5P影响卵巢癌化疗耐药的机制研究[D].郑州:郑州大学,2018.
[18] 程龙,徐五琴,张鹏,等.miR-140-5p调控类风湿关节炎滑膜成纤维细胞增殖和侵袭机制的研究[J].中国免疫学杂志,2019,35(3):345-349.
[19] 张俊,马冰,刘彩林.miR-140-5p对炎症模型支气管上皮细胞炎症因子分泌的影响[J].郑州大学学报(医学版),2021,56(3):350-355.
[20] NATALA S R,HABAS A,STOCKING E M,et al.Structure based design and synthesis of novel Toll-like receptor 2(TLR 2) lipid antagonists[J].Bioorg Med Chem Lett,2021,40(461):127861.
[21] WANG P,TIAN H,ZHANG Z,et al.EZH2 regulates lipopolysaccharide-induced periodontal ligament stem cell proliferation and osteogenesis through TLR4/MyD88/NF-κB pathway[J].Stem Cells Int,2021(4):1-12.
[22] 李莉玲,符淳.宫颈癌外周血单核细胞Toll样受体4、核因子κB表达变化与肿瘤增殖基因、侵袭基因的相关性[J].中国性科学,2021,30(9):69-73.

服务与反馈:
文章下载】【发表评论】【查看评论】【加入收藏
提示:您还未登录,请登录!点此登录
您是第 413408 位访问者


copyright ©《东南大学学报(医学版)》编辑部
联系电话:025-83272481 83272483
电子邮件:
bjb@pub.seu.edu.cn

苏ICP备09058364